Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | FABP7 | O15540 | 1/20 | 0.36 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27420244 | 0.98 | MMP13 (0.37) | MMP13EPHX2KMT2AFABP7FABP5 | |
| SCHEMBL27420232 | 0.88 | FABP7 (0.43) | EPHX2KMT2AFABP7FABP5TDP1 | |
| SCHEMBL27420215 | 0.86 | FABP7 (0.38) | EPHX2KMT2AFABP7FABP5TDP1 | |
| SCHEMBL27420200 | 0.86 | FABP7 (0.38) | EPHX2KMT2AFABP7FABP5TDP1 | |
| SCHEMBL27420226 | 0.79 | NAAA (0.50) | EPHX2KMT2AFABP7FABP5TDP1 | |
| SCHEMBL27420721 | 0.76 | KMT2A (0.35) | EPHX2KMT2ATDP1 | |
| SCHEMBL27421521 | 0.75 | KMT2A (0.39) | EPHX2KMT2ATDP1 | |
| SCHEMBL27421425 | 0.72 | KMT2A (0.38) | EPHX2KMT2AFABP7FABP5TDP1 | |
| SCHEMBL2906513 | 0.69 | FABP5 (0.42) | EPHX2KMT2AFABP7FABP5 | |
| SCHEMBL2568254 | 0.69 | KMT2A (0.50) | EPHX2KMT2AFABP7FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024092256-A2 | PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2024-05-02 | — | — | WO | disclosed |